Weekly mitoxantrone in the treatment of advanced pancreatic carcinoma: a Southeastern Cancer Study Group Trial
DeSimone, P.A.; Gams, R.; Bartolucci, A.
Cancer Treatment Reports 70(7): 929-930
1986
ISSN/ISBN: 0361-5960 PMID: 3521850 Document Number: 270738
Document emailed within 1 workday
Related Documents
Davis, R.B.; Van Echo, D.A.; Leone, L.A.; Henderson, E.S. 1986: Phase Ii trial of mitoxantrone in advanced primary liver cancer: a Cancer and Leukemia Group B Study Cancer Treatment Reports 70(9): 1125-1126Taylor, S.A.; Von Hoff, D.D.; Baker, L.H.; Balcerzak, S.P. 1984: Phase Ii clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study Cancer Treatment Reports 68(6): 919-920
Ravry, M.J.; Moore, M.R.; Omura, G.A.; Esseese, I.; Bartolucci, A. 1985: Phase Ii evaluation of cisplatin in squamous carcinoma of the esophagus: a Southeastern Cancer Study Group trial Cancer Treatment Reports 69(12): 1457-1458
Lawson, D.; Moore, M.; Smalley, R. 1980: An evaluation of hexamethylmelamine, cis-diamminedichloroplatinum, and mitomycin-C in advanced breast cancer. a pilot study of the Southeastern Cancer Study Group Cancer Clinical Trials 3(4): 293-296
Schulman, P.; Davis, R.B.; Rafla, S.; Green, M.; Henderson, E. 1984: Phase Ii trial of spirogermanium in advanced renal cell carcinoma: a Cancer and Leukemia Group B study Cancer Treatment Reports 68(10): 1305-1306
Gams, R.A.; Durant, J.R.; Bartolucci, A.A. 1982: Chemotherapy for advanced Hodgkin's disease: conclusions from the Southeastern Cancer Study Group Cancer Treatment Reports 66(4): 899-905
Carpenter, J.T.; Raney, M.; Logan, T. 1986: Phase Ii evaluation of procarbazine in metastatic breast cancer: a Southeastern Cancer Study Group Trial Cancer Treatment Reports 70(5): 679-680
Levin, M.; Pandya, K.J.; Khandekar, J.D.; Horton, J.; Glick, J.H.; Bennett, J.M.; Muggia, F.M.; Falkson, G. 1984: Phase Ii study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study Cancer Treatment Reports 68(12): 1511-1512
Gockerman, J.P.; Spremulli, E.N.; Raney, M.; Logan, T. 1986: Randomized comparison of tamoxifen versus diethylstilbestrol in estrogen receptor-positive or -unknown metastatic breast cancer: a Southeastern Cancer Study Group trial Cancer Treatment Reports 70(10): 1199-1203
Wadler, S.; Atkins, M.; Karp, D.; Neuberg, D.; Haynes, H.; Dutcher, J.P. 1998: Clinical trial of weekly intensive therapy with 5-fluorouracil on two different schedules combined with interferon alpha-2a and filgrastim in patients with advanced solid tumors: Eastern Cooperative Oncology Group Study P-Z991 Cancer Journal From Scientific American 4(4): 261-268
Sakata, Y.; Shimada, Y.; Yoshino, M.; Kambe, M.; Futatsuki, K.; Nakao, I.; Ogawa, N.; Wakui, A.; Taguchi, T. 1994: A late phase II study of CPT-11, irinotecan hydrochloride, in patients with advanced pancreatic cancer. CPT-11 Study Group on Gastrointestinal Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(7): 1039-1046
Ettinger, D.S.; Finkelstein, D.M.; Harper, G.R.; Ruckdeschel, J.C.; Chang, A.Y.; Camacho, F.J.; Marsh, J.C.; Silber, R.; Wolter, J.M. 1985: Phase Ii study of mitoxantrone, aclarubicin, and diaziquone in the treatment of non-small cell lung carcinoma: an Eastern Cooperative Oncology Group study Cancer Treatment Reports 69(9): 1033-1034
Koeppler, H.; Duru, M.; Grundheber, M.; Heymanns, J.; Jacobs, G.; Pandorf, A.; Rendenbach, B.; Schimke, J.; Weide, R. 2004: Palliative treatment of advanced pancreatic carcinoma in community-based oncology group practices Journal of Supportive Oncology 2(2): 159-163
Follézou, J.Y.; Palangie, T.; Feuilhade, F. 1987: Randomized trial comparing mitoxantrone with adriamycin in advanced breast cancer Presse Medicale 16(16): 765-768
Troner, M.B.; Hemstreet, G.P. 1981: Cyclophosphamide, doxorubicin, and cisplatin (CAP) in the treatment of urothelial malignancy: a pilot study of the Southeastern Cancer Study Group Cancer Treatment Reports 65(1-2): 29-32
Ogawa, M.; Kubo, K.; Tominaga, T.; Nomura, Y.; Ota, K.; Yoshida, M.; Taguchi, T.; Hoshino, A. 1986: Phase Ii study of mitoxantrone in advanced breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(5): 1980-1984
Murata, T.; Uda, M.; Nagata, K.; Harima, K.; Nishida, T.; Kawa, S.; Oshima, T.; Tanaka, Y.; Okuda, M.; Seki, Y. 1994: Clinical study of cyclic intra-arterial chemotherapy using mitoxantrone for advanced hepatocellular carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(12): 1991-1996
Kimura, M.; Sano, M.; Tabei, T.; Asaga, T.; Ando, J.; Fujii, H.; Yamamoto, N.; Kurosumi, M. 2005: Study of three-weekly docetaxel and weekly trastuzumab treatment in HER 2-overexpressing metastatic breast cancer patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(3): 335-339
Scotto, V.; Sbiroli, C. 1991: Weekly cis-platinum as third line chemotherapy in advanced ovarian carcinoma. Phase Ii study European Journal of Gynaecological Oncology 12(1): 51-53
Gordon, D.S. 1977: Clinical immunotherapy experiences in the Southeastern Cancer Study Group Developments in Biological Standardization 38: 567-572